Oyster Point Pharma Overview

Oyster Point Pharma Operating Income

Operating Income for OYST.

Quarterly Operating Income

$-33252000.00

↑ 98.31% YoY

As of Sep 30, 2022

Annual Operating Income (TTM)

$-164318000.00

↑ 105.51% YoY

Trailing 12 months ending Sep 30, 2022

Average Operating Income (Comparison Companies)

Operating Income History

Operating Income Comparison

Annual Operating Income Growth Rate (%)

Annual Operating Income Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin